Distribution of fenofibric acid in lipoprotein fractions of patients (Q77187755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Distribution of fenofibric acid in lipoprotein fractions of patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

M Nobilis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Kvetina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P Anzenbacher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

T Vontor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D Svoboda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

M Brátová

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D Solichová

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Z Zadák

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

V Bláha

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Vlcek

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Drug Metabolism and Pharmacokinetics

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

287-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9725495%20AND%20SRC:MED&resulttype=core&format=json

A systematic antilipidemic structure-activity relationship study was carried out on a series of alcoyl- and benzoyl-phenoxy-carboxylic acids

3 December 2019

cites work

1 reference

12 December 2020

Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV)

1 reference

12 December 2020

Pharmacology of fenofibrate

1 reference

12 December 2020

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

1 reference

12 December 2020

Rapid determination of procetofenic acid in plasma by high-performance liquid chromatography

1 reference

12 December 2020

Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man

1 reference

12 December 2020

The metabolism and disposition of 14C-fenofibrate in human volunteers

1 reference

12 December 2020

Antilipidemic drugs. Part 6: LF 178 in man. A preliminary note on a multicenter investigation bearing on 393 subjects with pure or mixed forms of hyperlipidemia

1 reference

12 December 2020

Identification of a major metabolite of the new hypolipidaemic agent, isopropyl 2-(4'(p-chlorobenzoyl) phenoxy)-2-methylpropionate (procetofene) in humans by gas chromatography-mass spectrometry

1 reference

12 December 2020

Gas—liquid chromatographic determination of procetofenic acid in human plasma and urine

1 reference

12 December 2020

Species differences in the chirality of the carbonyl reduction of [14C] fenofibrate in laboratory animals and humans

1 reference

12 December 2020

Simple and rapid method for determining procetofenic acid, an active metabolite of procetofen, in biological fluids by solid-phase extraction and high-performance liquid chromatography

1 reference

12 December 2020

The metabolism and disposition of fenofibrate in rat, guinea pig, and dog

1 reference

12 December 2020

Effect of a single daily dose treatment of fenofibrate on plasma lipoproteins in hyperlipoproteinaemia IIb

1 reference

12 December 2020

Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.

1 reference

12 December 2020

Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178)

1 reference

12 December 2020